We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Illustration

COVID-19 Patients Have Low Oxygen Levels Due to Damaged Blood Cells, Finds Study

A report by Reuters has stated that the damage caused by the coronavirus to the membranes of red blood cells that carry oxygen could explain why several COVID-19 patients have alarmingly low oxygen levels. More...
08 Jul 2020
Illustration

COVID-19 HPC Consortium Aids Use of Machine Learning and Molecular Modelling to Improve Drug Discovery

The COVID-19 High Performance Computing (HPC) Consortium has been launched to provide access to the world’s most powerful high-performance computing resources in support of COVID-19 research. More...
08 Jul 2020
Image: GSK Collaborates with Medicago to Develop Novel Adjuvanted COVID-19 Candidate Vaccine (Photo courtesy of Medicago)

GSK Collaborates with Medicago to Develop Novel Adjuvanted COVID-19 Candidate Vaccine

GlaxoSmithKline plc. (Brentford, UK) has entered into a collaboration with Medicago (Quebec City, Canada) to develop and evaluate an adjuvanted COVID-19 candidate vaccine. More...
08 Jul 2020
Image: Novavax Selected for Operation Warp Speed, Receives USD 1.6 Billion for COVID-19 Vaccine Development (Photo courtesy of Novavax, Inc.)

Novavax Selected for Operation Warp Speed, Receives USD 1.6 Billion for COVID-19 Vaccine Development

Novavax, Inc. (Gaithersburg, MD, USA) has been selected to participate in Operation Warp Speed (OWS), a US government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021. More...
08 Jul 2020
Image: LIAISON® MDX (Photo courtesy of DiaSorin Molecular LLC)

Diasorin CE Marks New Simplexa Flu A/B & RSV Direct Gen II Assay to Run with Simplexa COVID-19 Direct Assay

DiaSorin Molecular LLC (Cypress, CA, USA) has CE marked its Simplexa Flu A/B & RSV Direct Gen II kit to run alongside its Simplexa COVID-19 Direct kit. More...
08 Jul 2020
Image: qRT-PCR Workflow (Photo courtesy of Advanced Biological Laboratories)

Advanced Biological Releases First Commercial CE-IVD Registered COVID-19 rRT-PCR Assay Also Validated for Saliva

Advanced Biological Laboratories (ABL Luxembourg) has announced the CE-IVD marking of its UltraGene Combo2Screen SARS-CoV-2 qPCR assay. More...
08 Jul 2020
Image: Clinical Trials to Study Use of Low-Dose Radiation for Treatment of COVID-19 Infections (Photo courtesy of National Institutes for Health)

Clinical Trials to Study Use of Low-Dose Radiation for Treatment of COVID-19 Infections

Two clinical trials are underway to find out if low-dose, whole-lung radiation in the form of X-rays can effectively treat patients who have acute respiratory distress syndrome (ARDS) as a result of COVID-19 infection. More...
07 Jul 2020
New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Anterior Cervical Plate System
XTEND
New
Transducer Covers
Surgi Intraoperative Covers